Home > PJ > Contents

The Pharmaceutical Journal, December 1, 2001

Back issues

Previous  Next

Return to PJ Online Home Page

Leading Article   
   She came to bury pharmacy, not to praise it [more]

News & Features   
   News (including R & D and news in brief)
   What will new disciplinary and control powers for health authorities mean? [more]
   Is patent extension good for patients? [more]

Letters   
   Letters to the Editor

Continuing education   
   Diseases of the skin and their treatment: (2) Rosacea
   »(PDF*, 70K)

Original Papers   
   How are multi-compartment compliance aids used in primary care?
   »(PDF*, 80K)

Articles   
   Certification in oncology pharmacy — could the United States process be used in the UK?
   »(PDF*, 55K)
   Why I believe control of entry regulations must be maintained [more]

Meetings   
   Pharmacy development groups [more]

Onlooker

The Society   
   News
   Official notices
   Obituaries & tributes
   MEP: December amendments & tributes
   Statutory committee

Notice-board
   Branch meetings
   Future events
   Conferences
and more

Products


  * PDF files on PJ Online require Acrobat Reader 4 or later.


Front Cover Picture
This week's front cover picture (Christopher Icha) draws attention to our news feature which investigates issues surrounding patent expiries.

Remuneration
A 4 per cent increase over 10 years has been described as pitiful recompense.

NSAIDs protective in Alzheimer's disease
Computerised pharmacy records have been used to show that long-term use of NSAIDs protects against Alzheimer's disease.

Management of rosacea
This week's continuing education article describes the clinical features of rosacea and the pharmacist's role in its management.

Multi-compartment compliance aids
Research from Leeds concludes that the provision of compliance aids in primary care should be carefully targeted at patients who really need them.

Oncology pharmacy
An article looks at the oncology certification examination in the US and how applicable it might be to UK practice.

Recalls
G-Pharma Ltd has recalled Omnic (tamsulosin hydrochloride) 400µg capsules.


©The Pharmaceutical Journal